Department of Cardiovascular Surgery, Çiğli Training & Research Hospital, İzmir 35620, Turkey.
Department of Medical Biology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey.
Epigenomics. 2019 Sep;11(12):1387-1397. doi: 10.2217/epi-2019-0036. Epub 2019 Oct 9.
Identification of microRNAs (miRNAs) associated with atherosclerosis may unravel novel therapeutic targets and biomarkers. We studied miRNAs differentially expressed between coronary atherosclerotic plaques (CAP) and healthy arteries. Paired CAP and internal mammary arteries (IMA) were collected from 14 coronary artery disease patients. The miRNA profiles between diseased (CAP) and healthy (IMA) tissues were compared using microarrays and quantitative PCR. Thirty-one miRNAs were differentially expressed between CAP and IMA. Among these, miR-486-5p showed a high level of regulation (12-fold), had predicted interactions with atherosclerosis-associated genes and correlated with triglyceride levels and arterial stenosis. Regulation of miR-486-5p was validated by PCR (p = 0.004). The miRNAs are regulated in the atherosclerotic plaque. We highlight miR-486-5p whose role in atherosclerosis requires further investigation.
鉴定与动脉粥样硬化相关的 microRNAs(miRNAs)可能揭示新的治疗靶点和生物标志物。我们研究了冠状动脉粥样硬化斑块(CAP)和健康动脉之间差异表达的 miRNAs。从 14 名冠心病患者中收集配对的 CAP 和内乳动脉(IMA)。使用微阵列和定量 PCR 比较患病(CAP)和健康(IMA)组织之间的 miRNA 图谱。CAP 和 IMA 之间有 31 个 miRNAs 差异表达。其中,miR-486-5p 表现出高水平的调节(12 倍),与动脉粥样硬化相关基因具有预测的相互作用,并与甘油三酯水平和动脉狭窄相关。PCR 验证了 miR-486-5p 的调节(p=0.004)。miRNAs 在动脉粥样硬化斑块中受到调节。我们强调 miR-486-5p,其在动脉粥样硬化中的作用需要进一步研究。